Bionano Genomics (BNGO) Insider Trading & Ownership $0.23 0.00 (-0.31%) As of 01/10/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Bionano Genomics (NASDAQ:BNGO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.60%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$93,092.80Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$72,400.00 Get BNGO Insider Trade Alerts Want to know when executives and insiders are buying or selling Bionano Genomics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BNGO Insider Buying and Selling by Quarter Bionano Genomics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/13/2023Hannah MamuszkaDirectorBuy6,578$7.60$49,992.80 5/16/2023R. Erik HolmlinCEOBuy1,500$6.40$9,600.00 5/12/2023Christopher P StewartCFOBuy5,000$6.70$33,500.00 8/15/2022Yvonne LinneyDirectorSell2,000$36.20$72,400.00 (Data available from 1/1/2013 forward) BNGO Insider Trading Activity - Frequently Asked Questions Who is on Bionano Genomics's Insider Roster? The list of insiders at Bionano Genomics includes Christopher P Stewart, Hannah Mamuszka, R. Erik Holmlin, and Yvonne Linney. Learn more on insiders at BNGO. What percentage of Bionano Genomics stock is owned by insiders? 1.60% of Bionano Genomics stock is owned by insiders. Learn more on BNGO's insider holdings. Which Bionano Genomics insiders have been buying company stock? The following insiders have purchased BNGO shares in the last 24 months: Christopher P Stewart ($33,500.00), Hannah Mamuszka ($49,992.80), and R. Erik Holmlin ($9,600.00). How much insider buying is happening at Bionano Genomics? Insiders have purchased a total of 13,078 BNGO shares in the last 24 months for a total of $93,092.80 bought. Bionano Genomics Key ExecutivesDr. Robert Erik Holmlin M.B.A. (Age 56)Ph.D., President, CEO & Director Compensation: $612.62kMr. Mark Oldakowski (Age 50)Chief Operating Officer Compensation: $472.91kDr. Alka Chaubey FACMG (Age 51)Ph.D., Chief Medical Officer Compensation: $452.91kMs. Gulsen Kama M.B.A. (Age 51)Chief Financial Officer Mr. Mark Adamchak CPAVP of Accounting & ControllerMr. Jonathan Dixon J.D. (Age 49)General Counsel & Secretary Mr. Stanislas Marin M.B.A.M.S., Vice President of Global SalesMs. Donna PolizioGlobal Head of Market AccessMr. Cory KreeckGlobal Head of People OperationsDr. Klint Rose Ph.D.Head of Research & Development More Insider Trading Tools from MarketBeat Related Companies 908 Devices Insider Transactions Owlet Insider Transactions ClearSign Technologies Insider Transactions Singular Genomics Systems Insider Transactions Optex Systems Insider Transactions Rapid Micro Biosystems Insider Transactions Autoscope Technologies Insider Transactions Accelerate Diagnostics Insider Transactions Data I/O Insider Transactions Astrotech Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop BuyingAppLovin Insiders Sell Shares: Stock Price Indicated Higher This page (NASDAQ:BNGO) was last updated on 1/13/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
